Byrna Technologies posted fiscal third-quarter revenue of USD 15.3 million, down roughly 46% from USD 28.2 million a year earlier, alongside a net loss of USD 2.9 million, or USD 0.13 per share. The
Tilray Brands moved quickly to position itself inside the U.S. medical cannabis market this week after federal regulators approved a partial rescheduling of marijuana products under the Controlled
Ascend Wellness Holdings has filed applications with the U.S. Drug Enforcement Administration to register its state-licensed medical cannabis operations under the expedited registration pathway tied
